# Butterfly’s Blind-Sweep GA Tool Cleared — AI Ultrasound Without the Sonographer

Times of AI Desk · 2026-03-30 · Enterprise

[https://timesof.ai/2026/03/butterfly-network-ultrasound-ai-tool-fda-clearance](https://timesof.ai/2026/03/butterfly-network-ultrasound-ai-tool-fda-clearance)

> Butterfly Network won FDA clearance for a fully automated Gestational Age tool on handheld ultrasound — first cleared blind-sweep AI for pregnancy dating. Trained on 21M+ images with UNC; claims equivalence to sonographer biometry (16–37 weeks) in under two minutes. Already in Malawi/Uganda via Gates support; clearance is the U.S. scale gate, not a outcomes trial.

Prenatal dating usually needs a trained sonographer. Butterfly’s proprietary frame is **FDA clearance for a blind-sweep AI** that claims biometry-equivalent gestational age from a guided handheld sweep — access story first, clinical outcomes still to prove at scale.

**Butterfly Network** (March 30) received FDA clearance for a fully automated **Gestational Age (GA) Tool** on its handheld ultrasound. Company and wire framing: first FDA-cleared blind-sweep ultrasound AI for estimating gestational age. Workflow: enter fundal height, apply gel, perform guided sweeps — results in **under two minutes**, minimal training required. Deep-learning models developed with the **University of North Carolina at Chapel Hill**; trained on **more than 21 million** images across diverse demographics. Performance claimed **equivalent to standard biometry** for patients **16–37 weeks** gestation.

Already deployed in **Malawi** and **Uganda** with **Gates Foundation** grant support. Clearance opens broader U.S. rural and Sub-Saharan rollout. Sachita Shah, MD (VP Global Health): maternal imaging access as urgent priority; Steve Cashman (CBO) flags emergency, high-mortality, and rural U.S. use cases.

## Claims vs checks

Clearance and product description are **Butterfly primary** (press release) plus Reuters same-day. Equivalence to sonographer biometry is company/clinical claim tied to the clearance package — not an independent Times of AI audit. LMIC deployments are grant-backed pilots, not population-outcome RCTs published with this release.

## Limits

- FDA clearance ≠ proven maternal/fetal mortality reduction.
- Performance band is 16–37 weeks; outside that window is out of scope here.
- Handheld + AI still needs power, gel, and workflow adoption.

## Sources

- [Butterfly Network: “Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool…”](https://www.butterflynetwork.com/press-releases/fda-cleared-gestational-age-tool) (March 30, 2026).
- Reuters: “Butterfly Network gets FDA clearance for AI ultrasound pregnancy tool” (March 30, 2026).